A pharmaceutical composition for treating a blood clotting disorder comprising a therapeutically effective amount of a composition comprising isolated adamts13

摘要

This invention relates to methods of subcutaneous administration of ADAMTS13 formulations to a treat a disease or condition associated with ADAMTS13 and VWF dysfunction. Furthermore, evidence of the unexpectedly high bioavailability of ADAMTS13 formulations administered subcutaneously is provided herein.